Literature DB >> 9799485

DNA polymerase III of Gram-positive eubacteria is a zinc metalloprotein conserving an essential finger-like domain.

M H Barnes1, C J Leo, N C Brown.   

Abstract

DNA polymerase III (pol III) of Gram-positive eubacteria is a catalytically bifunctional DNA polymerase:3'-5' exonuclease [Low, R. L., Rashbaum, S. A., and Cozzarelli, N. R. (1976) J. Biol.Chem. 251, 1311-1325]. The pol III protein conserves, between its exonuclease and dNTP binding sites, a 35-residue segment of primary structure with the potential to form a zinc finger-like structure [Berg, J. M. (1990) Ann. Rev. Biochem. 19, 405-421]. This paper describes results of experiments which probe the capacity of this segment to bind zinc and the role of this segment in enzyme function. The results of metal and mutational analysis of a model pol III derived from Bacillus subtilis indicate that (i) the Gram-positive pol III is a metalloprotein containing tightly bound zinc in a stoichiometry of 1, (ii) the zinc atom is bound within the 35-residue segment, likely in one of two probable finger-like structures, and (iii) the integrity of the zinc-bound structure is specifically critical to the formation and/or function of the enzyme's polymerase site.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9799485     DOI: 10.1021/bi981113m

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Structure of PolC reveals unique DNA binding and fidelity determinants.

Authors:  Ronald J Evans; Douglas R Davies; James M Bullard; Jeffrey Christensen; Louis S Green; Joseph W Guiles; Janice D Pata; Wendy K Ribble; Nebojsa Janjic; Thale C Jarvis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-23       Impact factor: 11.205

2.  Inhibitors of DNA polymerase III as novel antimicrobial agents against gram-positive eubacteria.

Authors:  P M Tarantino; C Zhi; G E Wright; N C Brown
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

3.  Low frequencies of resistance among Staphylococcus and Enterococcus species to the bactericidal DNA polymerase inhibitor N(3)-hydroxybutyl 6-(3'-ethyl-4'-methylanilino) uracil.

Authors:  Michelle M Butler; Donna J Skow; Ryan O Stephenson; Patrick T Lyden; William A LaMarr; Kimberly A Foster
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

4.  In vitro antimicrobial activities of novel anilinouracils which selectively inhibit DNA polymerase III of gram-positive bacteria.

Authors:  J S Daly; T J Giehl; N C Brown; C Zhi; G E Wright; R T Ellison
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

5.  DNA polymerases of low-GC gram-positive eubacteria: identification of the replication-specific enzyme encoded by dnaE.

Authors:  Marjorie H Barnes; Shelley D Miller; Neal C Brown
Journal:  J Bacteriol       Date:  2002-07       Impact factor: 3.490

Review 6.  Replicative DNA polymerases.

Authors:  M Albà
Journal:  Genome Biol       Date:  2001-01-12       Impact factor: 13.583

7.  In silico screening for novel inhibitors of DNA polymerase III alpha subunit of Mycobacterium tuberculosis (MtbDnaE2, H37Rv).

Authors:  Alka Jadaun; Raja Sudhakar D; N Subbarao; Aparna Dixit
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

8.  Adaptations to submarine hydrothermal environments exemplified by the genome of Nautilia profundicola.

Authors:  Barbara J Campbell; Julie L Smith; Thomas E Hanson; Martin G Klotz; Lisa Y Stein; Charles K Lee; Dongying Wu; Jeffrey M Robinson; Hoda M Khouri; Jonathan A Eisen; S Craig Cary
Journal:  PLoS Genet       Date:  2009-02-06       Impact factor: 5.917

9.  Identification of potential drug targets by subtractive genome analysis of Escherichia coli O157:H7: an in silico approach.

Authors:  Shakhinur Islam Mondal; Sabiha Ferdous; Nurnabi Azad Jewel; Arzuba Akter; Zabed Mahmud; Md Muzahidul Islam; Tanzila Afrin; Nurul Karim
Journal:  Adv Appl Bioinform Chem       Date:  2015-12-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.